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ABSTRACT
Chemokines are small, soluble proteins that regulate leukocyte migration, adhesion, and
proliferation. Recent evidence suggests that chemokine receptors are expressed in the central
nervous system and that their functions extend beyond their roles in inflammation. Specific
chemokines and their receptors are implicated in cerebellar development. In this study, we
evaluated the expression of -chemokine receptor CCR1 in the immature and adult rat
cerebellum and report striking developmental changes in CCR1 expression. Reverse tran-
scriptase polymerase chain reaction assays of cerebellum revealed moderate increases in
CCR1 mRNA expression from postnatal day (P) 3 to adulthood. Light and confocal microscopy
were used to evaluate developmental changes in the neuroanatomical and cell-specific dis-
tribution of CCR1 immunoreactivity. CCR1 immunoreactivity was detected as early as P3
and peaked between P7 and P21. The predominant CCR1-immunoreactive neuronal cell
types included granule cells of the internal granular layer, Purkinje cells, Golgi cells, and
molecular layer interneurons; Bergmann glia, astrocytes, and resting microglia also ex-
pressed CCR1. In contrast, granule cells in the external germinal layer, descending granule
cells, and activated microglia rarely expressed CCR1. We also evaluated the expression of the
CCR1 ligand macrophage inflammatory protein-1 (MIP-1/CCL3). Two cell populations
expressed MIP-1: physiologically activated microglia in white matter (P7–P14) and Purkinje
cells (P7–adult). MIP-1-positive cells were frequently located near the processes and cell
bodies of CCR1-immunoreactive cells, during times of neuronal and glial maturation (second
and third postnatal weeks). These findings provide support for the hypothesis that CCR1
plays a role in postnatal cerebellar development. J. Comp. Neurol. 457:7–23, 2003.
© 2003 Wiley-Liss, Inc.
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Chemokines constitute a group of small (8–13 kD), sol-
uble, structurally related proteins that attract leukocytes
to sites of infection or injury through interactions with
G-protein-coupled receptors (Locati and Murphy, 1999).
Chemokines are classified as CC (-chemokine), CXC (-
chemokine), XC, or CX3C group members, based on the
sequence of the cysteine motif near their amino termini.
There is growing recognition that chemokines play diverse
and complex roles in central nervous system development
and disease (Asensio and Campbell, 1999; Mennicken et
al., 1999). Recent work has demonstrated that neurons,
astrocytes, and microglia can express multiple chemo-
kines and chemokine receptors in vitro and in vivo (Hes-
selgesser and Horuk, 1999; Mennicken et al., 1999); the
functionality of these receptors has been characterized in
vitro. Chemokines can regulate neurotransmission (Gio-
vannelli et al., 1998; Klein et al., 1999; Limatola et al.,
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2000) and neuronal/astrocytic migration (Hesselgesser et
al., 1997; Tanabe et al., 1997) and survival (Hesselgesser
et al., 1998; Meucci et al., 1998, 2000; Kaul and Lipton,
1999; Bakhiet et al., 2001; Gillard et al., 2002). In vivo,
certain chemokine receptors are expressed constitutively
in the developing and adult brain (Hesselgesser and Ho-
ruk, 1999; Mennicken et al., 1999), and chemokine expres-
sion is induced or upregulated in many neuropathological
conditions, including multiple sclerosis (Balashov et al.,
1999), stroke (Stanimirovic and Satoh, 2000), and Alzhei-
mer’s disease (Horuk et al., 1997; Xia and Hyman, 1999).
Recent studies highlight the roles of specific chemokines
and chemokine receptors in cerebellar physiology and de-
velopment. Gillard et al. (2002) documented the expres-
sion of multiple functional chemokine receptors in rat
cerebellar granule and Purkinje neurons in vitro, and
several chemokine receptors have been identified in vivo
in normal mammalian cerebellum, including CXCR2,
Duffy antigen receptor for chemokines (DARC) (Horuk et
al., 1997), CXCR3 (Goldberg et al., 2001), and CCR3 (Van
Der Meer et al., 2001). Overexpression (interleukin-3 [IL-
3], cytokine-induced neutrophil chemoattractant (KC),
6Ckine) or depletion (IL-6) of certain cytokines or chemo-
kines in mice results in gliosis, abnormal leukocyte infil-
tration into cerebellar white matter and parenchyma, and
behavioral abnormalities (ataxia, rigidity, postural insta-
bility, and/or tremor; Campbell et al., 1993; Tani et al.,
1996; Sugita et al., 1999; Chen et al., 2002). Moreover,
ablation of the -chemokine receptor CXCR4 and its li-
gand stromal cell derived factor 1 (SDF-1) leads to cere-
bellar malformation and abnormal granule cell migration
(Ma et al., 1998; Zou et al., 1998).
In a recent study of the role of the -chemokine macro-
phage inflammatory protein 1 (MIP-1/CCL3) in neona-
tal brain injury, we found that neurons and astrocytes of
the 7-day-old (P7) rat forebrain expressed the MIP-1
receptor CCR1; in preliminary immunohistochemistry as-
says of adult brain, no CCR1 was detected (Cowell et al.,
2002). This finding prompted us to hypothesize that CCR1
expression is developmentally regulated in the rat brain.
In light of the evidence cited above suggesting that che-
mokines and their receptors contribute to cerebellar de-
velopment, in this study we evaluated the expression of
CCR1 in the developing cerebellum. Using a semiquanti-
tative reverse transcriptase polymerase chain reaction as-
say, we demonstrated that CCR1 mRNA is expressed in
rat cerebellum. In addition, we used immunohistochemis-
try with light and confocal microscopy to document that
CCR1 protein is expressed in neuronal and glial cells
during rat cerebellar development, specifically during
times of neurite extension and cell maturation. Further-
more, immunohistochemistry assays revealed that
MIP-1 is expressed in microglia of cerebellar white mat-




Primary antibodies and reagents included goat anti-rat
CCR1 (recognizes carboxyl terminal [intracellular do-
main]), CCR1 blocking peptide, goat anti-rat CCR5 (all
from Santa Cruz Biotechnology, Santa Cruz, CA), mouse
anti-NeuN (Chemicon, Temecula, CA), mouse anti-
calbindin (Sigma, St. Louis, MO), mouse anti-human
GFAP (Sigma), rabbit anti-bovine GFAP (Dako, Carpen-
teria, CA), isolectin B4-peroxidase (Sigma), isolection B4-
fluorescein isothiocyanate (FITC; Sigma), mouse anti-
endothelin 1 (ED1; Serotec, Oxford, UK), mouse anti-rat
23-cyclic nucleotide 3-phosphodiesterase (CNPase;
Sternberger Monoclonals, Lutherville, MD), rabbit anti-
rat regulated upon activation normal T-cell-expressed and
–secreted (RANTES; Peprotech, Rocky Hill, NJ), rabbit
anti-rat MIP-1 (Peprotech), and rabbit anti-rat dou-
blecortin (DCx; generous gift of Dr. Jack Parent, Univer-
sity of Michigan, Ann Arbor, MI). Secondary antibodies
and reagents included biotinylated goat anti-rabbit, horse
anti-goat, and horse anti-mouse IgG (with minimum
cross-reactivity for rat serum proteins; Vector Laborato-
ries, Burlingame, CA), and CY2 donkey anti-mouse IgG
(Fab fragments; minimal cross-reactivity for goat, rabbit,
and rat serum proteins), CY3 donkey anti-goat IgG (Fab
fragments; minimal cross-reactivity for rabbit, mouse, and
rat serum proteins), and CY5 donkey anti-rabbit IgG (Fab
fragments; minimal cross-reactivity for rat, goat, and
mouse serum proteins) from Jackson ImmunoResearch
(West Grove, PA). All other reagents were purchased from
Sigma unless otherwise noted.
Reverse transcriptase polymerase
chain reaction
Unsexed Sprague-Dawley rats (Charles River, Wilming-
ton, MA) were decapitated on P3, P7, P14, P21, and P60
(n  3/group), and the brains were rapidly removed on ice.
The cerebellum was separated from the brainstem, ho-
mogenized in Tri-Reagent (Molecular Research Center,
Cincinnati, OH), and stored at 70°C. Two cerebella were
pooled for the P3 samples; one cerebellum/sample was
used for older animals. For a positive control, samples
were also obtained from adult spleen, which is enriched in
chemokine receptors. RNA was isolated, and RT-PCR was
performed as previously described (Galasso et al., 2000),
Abbreviations
5B4-CAM 5B4-cellular adhesion molecule
CCR1 -chemokine receptor 1
CNPase 23-cyclic nucleotide 3-phosphodiesterase
CTX cerebellar cortex
CV cresyl violet
DARC Duffy antigen/receptor for chemokines
DCX doublecortin
DN deep nucleus
EGL external germinal layer
EGLd EGL, differentiating zone
EGLm EGL, mitotic zone
GAPDH reduced glyceraldehyde-phosphate dehydrogenase
GFAP glial fibrillary acidic protein
IGL internal granular layer
IP immunogenic peptide
KC cytokine-induced neutrophil chemoattractant
MIP-1 macrophage inflammatory protein-1
ML molecular layer
NeuN neuron specific nuclear protein
P postnatal day
PI3-K phosphatidyl inositol-3 kinase
PL Purkinje cell layer
Pyk2/RAFTK proline-rich tyrosine kinase/related focal adhesion ty-
rosine kinase
SDF-1 stromal cell-derived factor 1
STAT signal transducer
WM white matter
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with minor modifications. Total RNA (1 g) was pre-
treated with DNase (15 minutes, 25°C), the reaction was
stopped with 2.5 mM EDTA, and DNase was heat-
inactivated (15 minutes, 65°C). Dnase-treated RNA was
incubated with 50 U murine leukemia virus (MuLV) RT, 2
mM random hexamers, and 0.5 mM of each dNTP in a
reaction volume of 25 l under the following conditions: 5
minutes, 25°C; 30 minutes, 42°C; 5 minutes, 99°C; 1
minute, 4°C. The RT product was diluted to a final volume
of 100 l in sterile water.
Oligonucleotide primer sets were generated to amplify
fragments of rat CCR1 (Boddeke et al., 1999) and glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH; internal
standard). CCR1: 5-GGA GTT CAC TCA CCA TAC CTG
TAG-3; 5-GGT CCA GAG GAG GAA GAA-3; GAPDH:
5-ACC ACC ATG GAG AAG GCT GG-3; 5-CTC AGT
GTA GCC CAG GAT GC-3. GAPDH RNA was assayed
concurrently to evaluate the equivalence of RNA content
among samples. Preliminary experiments established con-
ditions within the linear range of coamplification for
CCR1/GAPDH (15 l RT product; 0.2 mol/liter CCR1
primers, 0.04 mol/liter GAPDH primers; 94°C, 60 sec-
onds; 60°C, 60 seconds; 72°C, 90 seconds; 35 cycles). RT-
PCR reaction products were visualized in ethidium
bromide-stained 1.5% agarose gels, and results were
quantified by fluorometric scanning and the measurement
of arbitrary optical density units (counts/mm/band), using
the Molecular Analyst Imaging System (Bio-Rad, Her-
cules, CA).
Immunohistochemistry
Rats were deeply anesthetized with chloral hydrate (300
mg/kg) on P3, P7, P14, P21, and P60 (n  3/group) and
perfused intracardially with 0.1 M phosphate-buffered sa-
line (PBS, pH 7.4) and 4% paraformaldehyde. Brains were
removed, postfixed overnight in paraformaldehyde at 4°C,
cryoprotected in graded sucrose solutions, embedded in
Tissue-Tek OCT (VWR, Batavia, IL), frozen, and stored at
70°C (Ivacko et al., 1996). Serial sections of the cerebel-
lar hemispheres in the translobular (sagittal) plane were
mounted on gelatin-coated slides (15-m sections for light
microscopy and 30 m for confocal microscopy). Slides
were dried overnight and either used the next day or
stored at 70°C.
Antibodies were diluted in PBS with 5% serum (same
species as the host of the secondary antibody) and 0.3%
Triton X-100. Sections were washed, blocked in 10% nor-
mal serum, and incubated with the primary antibody
overnight at 4°C. Sections were then washed, incubated
with a biotinylated secondary antibody, rinsed with 0.3%
H2O2 in methanol, and washed before incubation with the
avidin-biotin conjugate (Vectastain ABC Elite kit, Vector).
Immunoreactivity was visualized with diaminobenzidine
(DAB) as the chromogen (Research Genetics, Huntsville,
AL). Sections were either counterstained briefly with cr-
esyl violet or directly dehydrated and coverslipped with
Permount.
To confirm the specificity of CCR1 immunostaining,
CCR1-blocking peptide (10-fold excess w/w) was incubated
with the anti-CCR1 antibody, undiluted, for 1 hour in PBS
at room temperature. The peptide-antibody mixture was
then diluted (to the same final concentration as for CCR1
immunohistochemistry) and substituted for the primary
antibody. This CCR1 antibody has been used successfully
to detect receptor upregulation by flow cytometry on as-
trocytes (Han et al., 2000) and neutrophils (Johnston et
al., 1999). Adult rat spleen sections were used as positive
controls for the detection of CCR1 and CCR5. For the
negative controls in all other immunohistochemistry ex-
periments, primary antibodies were replaced with an
equal concentration of species-matched nonspecific IgG.
Preliminary analysis was performed using light micros-
copy. Representative images were captured using a SPOT
camera attached to a Nikon Microphot-SA with 4, 10,
20, and 40 objectives, and images were directly im-
ported into Adobe Photoshop 5.5 for the adjustment of
brightness, contrast, and sharpness. Multiple fields were
captured and merged for areas too large to fit into one field
(Fig. 2, P14, P21; Fig. 3, adult).
Immunofluorescence
After incubation with the primary antibodies (overnight
at 4°C), sections were washed, incubated with the appro-
priate secondary antibodies (2 hours, room temperature),
washed, and coverslipped with aqueous anti-fade media
(Molecular Probes, Eugene, OR). Each experiment in-
cluded controls in which an equal concentration of species-
matched IgG was substituted for the primary antibody.
Immunofluorescence was visualized in triple-channel
mode on a Nikon Diaphot 200 microscope equipped with a
Noran confocal laser scanning imaging system and Silicon
Graphics Indy workstation. Data were collected from each
channel sequentially, and barrier filters minimized chan-
nel leakthrough (500/25 bandpass barrier filter in the
FITC/CY2 range; 605/55 bandpass barrier filter in the
rhodamine/CY3 range). In some cases, immunofluores-
cence was collected at 0.5-m intervals over 3–10 m
thickness (Z-series) to visualize cellular processes. With
Adobe Photoshop 5.5, the images from two or three chan-
nels were merged, and the brightness and contrast of the
images were adjusted.
Qualitative evaluation of CCR1
immunoreactivity
The distribution and intensity of CCR1 immunoreactiv-
ity were systematically evaluated to assess developmental
trends. Intensity of CCR1 immunoreactivity in 10 distin-
guishable cell populations was ranked on a 4-point scale
(, most intense to , absent). Intensity was assessed
with light microscopy (at magnifications of 100 and
200), and specific cell types were identified by their
morphology and location (with reference to the confocal
microscopy results). Conclusions were based on evaluation
of immunoreactivity in lobes VI–IX, in two sections from
each age group, assayed concurrently. Trends were con-
firmed in three separate experiments (one animal/group/
experiment).
RESULTS
Developmental change in CCR1
RNA expression
Using RT-PCR assays, CCR1 mRNA was detected in P3,
P7, P14, and P21 and in adult (P60) cerebellar tissue (Fig.
1). Densitometric analysis indicated that there was a mod-
est increase in expression between P3 and adult (50%
increase; n  3/group; P  0.05, Kruskal-Wallis test).
Expression levels in P7, P14, and P21 cerebellum were
intermediate and did not differ from one another.
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Developmental changes in CCR1
immunoreactivity
To determine the neuroanatomical and cell-specific dis-
tribution of CCR1 protein expression, cerebellar tissue
sections were analyzed by immunohistochemistry. Figure
2 illustrates the developmental changes in distribution
and intensity of cerebellar CCR1 immunoreactivity from
P3 to adulthood. CCR1 immunoreactivity is abolished in
serial sections for which the primary antibody was incu-
bated with the immunogenic blocking peptide (IP; Fig. 2).
Numerous cells throughout the cerebellar cortex are la-
beled lightly on P3; immunostaining is more intense from
P7 to P21 and declines in adulthood. The intensity and
distribution of CCR1 immunoreactivity (detailed below) is
similar in all lobes.
CCR1-immunoreactive cells are located in the Purkinje
cell layer (PL), internal granular layer (IGL), deep nucleus
(DN), and molecular layer (ML) at different ages (all neu-
roanatomical nomenclature from Altman and Bayer,
1997). CCR1 immunoreactivity is also evident on cells
within P3 (Fig. 2A2), P7 and P14 white matter (WM; see
Fig. 5). Large cells in the forming PL are CCR1-positive at
P3 (Fig. 2A2), P7 (Fig. 2B2), and P14 (Fig. 2C2). Smaller
immunoreactive cells are observed in the IGL from P7 to
adulthood (Fig. 2B2,C2,D2,E2). In the DN, there are large
CCR1-immunoreactive cells on P3, P7, and P14 (Fig.
2A3,B3,C3, respectively); however, very little CCR1 immu-
noreactivity is detectable in P21 and adult DN (data not
shown). It is especially evident in this cell type that CCR1
immunoreactivity is cytoplasmic (Fig. 2A3,C3) and nuclear
(Fig. 2B3, arrowhead). Within the molecular layer (ML),
few CCR1-immunoreactive cells are observed at P7 (Fig.
2B2), but at P14, cells intensely immunoreactive for CCR1
are concentrated at the ML/PL border (Fig. 2C2). Immu-
noreactive cells are distributed throughout the ML at P21
(Figs. 2D2,D3) but are absent from the adult ML (Fig.
2E3).
Figure 3 highlights the changes in CCR1 distribution
between P7 and P21 in cerebellar cortex. During this time,
the ML expands, the external germinal layer (EGL) thins,
and the Purkinje cells form a monolayer. These structural
changes are evident in cresyl violet-stained sections (Fig.
3, left column). CCR1-immunostained serial sections are
represented in the center column (Figs 3A2,B2,C2, respec-
tively) and the negative controls in the right column (Fig.
3A3,B3,C3).
At P7 (Fig. 3A2), many cells are immunoreactive for
CCR1; large cells in the PL are the most prominent (Fig.
3A2, arrowheads). Numerous cells throughout the IGL
and adjacent white matter are immunoreactive, including
several immunoreactive Golgi cells (Fig. 3A2, arrows).
Few cells in the ML express CCR1 (Fig. 3A2, open arrow).
On P14, only a few large cells are immunoreactive in the
PL (Fig. 3B2, arrowheads); however, many small, in-
tensely immunoreactive cell bodies are concentrated
within and just superficial to the PL (Fig. 3B2, solid ar-
rows). Small immunoreactive cells are also seen in the
lower molecular layer (Fig. 3B2, open arrows). Note that a
small fraction of descending granule cells is immunoreac-
tive (Fig. 3B2, open arrowhead; compare with the fre-
quency of similarly shaped cells in Fig. 3B1).
On P21 in the PL, only small cell bodies are immunore-
active, and immunostaining within the IGL is less intense
(Fig. 3C2). In contrast to P7 and P14 cerebellum, numer-
ous cell bodies throughout the ML express CCR1. Small
cell bodies in the upper ML display intense immunoreac-
tivity uniformly throughout the cell body (Fig. 3C2, arrow-
heads), and cells in the lower ML exhibit immunoreactiv-
ity limited to the cytoplasm and cell surface (Fig. 3C2,
arrows).
Cerebellar sections from each age group were analyzed
concurrently for CCR5 immunoreactivity. No CCR5 im-
munoreactivity was detected until P21; immunoreactivity
was limited to endothelium and pia in P21 and adult
cerebellum (not shown).
Identification of CCR1-expressing cell types
To determine the identity of CCR1-expressing cells and
to reveal maturational changes in the morphology and
distribution of neuronal and non-neuronal cells, we per-
formed immunohistochemistry on serial cerebellar sec-
tions with the CCR1 antibody and cell-specific markers.
We used antibodies or lectins specific for neurons (anti-
NeuN), Purkinje cells (anti-calbindin), Bergmann/radial
glia and astrocytes (anti-GFAP), and resting microglia
and capillary endothelium (isolectin). In Figure 4, the
distributions of these antigens are compared with cresyl
violet staining (Fig. 4A) and CCR1 immunohistochemistry
(Fig. 4B).
The neuron-specific protein NeuN (Fig. 4C) is expressed
in many cells in the EGL and IGL and in scattered cells
throughout the ML, in a pattern similar to that of granule
cells. Although little CCR1 is expressed in the EGL (Fig.
4B), CCR1-positive cells in the IGL at P7, P14, and P21
(Fig. 4B) have the same size and shape as NeuN-positive
cells (Fig. 4C), suggesting that CCR1 is expressed in gran-
ule cells of the IGL. In contrast, at P21 NeuN and CCR1
immunoreactivity differs substantially in the ML; compar-
ison of cresyl violet and NeuN staining at P21 (Fig.
4A3,C3) indicates that many of the cresyl violet-stained
cells with the morphology of ML interneurons (large round
cells in the lower ML and smaller cells in the upper ML)
express little detectable NeuN. These presumptive ML
interneurons, however, are similar in morphology to
CCR1-positive cells in the ML (Fig. 4B3).
In the cerebellum, the calcium-binding protein calbi-
ndin is concentrated in Purkinje cells. Calbindin immuno-
staining reveals that Purkinje cells form a monolayer by
P7 (Fig. 4D1), and their dendrites extend into the molec-
ular cell layer at P14 (Fig. 4D2), forming a dense network
in the ML by P21 (Fig. 4D3). When CCR1 and calbindin
Fig. 1. Semiquantitative RT-PCR assay of CCR1 mRNA. RNA was
isolated from rat cerebellum (P3, P7, P14, P21, adult) and adult
spleen (positive control), reverse transcribed, and amplified with
CCR1- and GAPDH-specific primers (see Materials and Methods).
CCR1 mRNA content (normalized to GAPDH mRNA) was 50% higher
in the adult cerebellum than in P3 cerebellum (see Results). For
abbreviations, see list.
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Fig. 2. CCR1 immunoreactivity in the developing and mature rat
cerebellum. Low-power image montages of CCR1-immunostained cer-
ebellar tissue, sectioned in the translobular (sagittal) plane, are pre-
sented in the left column. Boxed areas identify specific regions, shown
at higher power in the middle and right columns. Serial sections were
processed concurrently using primary antibody preincubated with an
immunogenic peptide (IP; see Materials and Methods) and are dis-
played to the right of the corresponding CCR1 immunohistochemistry
section; minimal nonspecific staining was detected in all sections.
A: On P3, scattered cells are immunoreactive for CCR1 within the PL
and WM (A2), and large ovoid cells are immunoreactive in the DN
(A3). B: Similarly, on P7, large cells in the PL (B2), smaller cells in the
forming IGL (B2), and large cells in the DN (B3) stain darkly for CCR1.
Some cells in the DN display nuclear CCR1 immunoreactivity (B3,
arrowhead). C: On P14, CCR1 immunoreactivity intensifies in the
IGL and in cells along the PL/ML border (C2). Immunopositive cells
are also seen in the ML (C2). Large cells in the DN display cytoplasmic
and cell surface immunoreactivity (C3). D: On P21, there are immu-
nopositive cells in the IGL (D2) as well as throughout the lower and
upper ML (D2 and D3, respectively). E: In the adult cerebellum, faintly
immunoreactive cells are located in the IGL (E2), whereas there are no
immunopositive cells in the ML (E3). For abbreviations, see list. Scale
bars  250 m in A1; 500 m in B1; C1-E1, 1 mm in C1–E1; 25 m in
all other panels.
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immunoreactivity distributions are compared at P7 (Fig.
4B1,D1, respectively), it is not possible to determine
whether Purkinje cells express CCR1, but calbindin-
positive Purkinje cells are clearly CCR1-negative at P21
(Fig. 4B3, arrows, and D3).
From P7 to P21, GFAP-positive Bergmann glia ma-
ture and form distinct radial fibers (Fig. 4E). On P14,
GFAP is concentrated in glial cell bodies and through-
out the radial processes (Fig. 4E2, arrowheads). The
GFAP staining of Bergmann glial cell bodies resembles
the CCR1 immunostaining in the PL and lower ML at
P14 (Fig. 4B2, arrowheads). Other glia of the cerebellar
cortex include the astrocytes and the resting microglia
of the IGL. Relatively few astrocytes (Fig. 4E2) and
resting microglia (distinguishable from capillaries by
their elaborate processes; Fig. 4F1–F3, arrowheads) are
present in the IGL from P7 to P21, indicating that most
CCR1-immunoreactive cells in the IGL are not astro-
cytes or microglia.
Figure 5 illustrates the developmental changes in the
distribution of CCR1 immunostaining and cell types in the
cerebellar white matter from P7 to P21. We observed
many CCR1-positive cells in the white matter on P7 and
P14, in areas devoid of neurons (Fig. 5, compare B1 and
C1, B2 and C2). We used immunohistochemistry to identify
astrocytes (GFAP), activated microglia (ED1), and oligo-
dendroglial processes and cell bodies (CNPase) (Fig. 5D–
F). From P7 to P21, numerous astrocytes are concentrated
in the white matter (Fig. 5D); the density of GFAP-
positive cell bodies and processes is the highest at P14
(Fig. 5D2). On P7 and P14, activated microglia reside in
the white matter (Fig. 5E1,E2), but at P21, no ED1-
positive microglia are present. CNPase immunostaining is
absent in P7 white matter (Fig. 5F1) but is readily dis-
cerned at P14 (Fig. 5F2) and P21 (Fig. 5F3). The distribu-
tion of CCR1 immunostaining is similar to the distribu-
tion of GFAP and ED1 staining, but the precise
identification of CCR1-expressing cell types required the
incorporation of double- and triple-labeling immunofluo-
rescence experiments (see below).
MIP-1 expression in postnatal
and adult cerebellum
The widespread distribution of CCR1 immunoreactivity
in the developing cerebellum prompted us to evaluate the
expression of the CCR1 ligands MIP-1 and RANTES
(/CCL5). No RANTES immunoreactivity was detectable at
any developmental age (not shown), but we observed MIP-
1-immunoreactive cells in the P7-adult cerebellum (Fig.
6). MIP-1-immunoreactive cells included Purkinje cells
(Fig. 6B–E) and cells in P7 and P14 white matter (Fig. 6F).
Figure 6F illustrates the distinctive juxtanuclear MIP-1
immunostaining pattern (Lore et al., 1998; Cowell et al.,
2002) observed in large cell bodies within white matter
tracts in P7 and P14 animals (Fig. 6F1). In serial sections,
these cells stain darkly for the monocyte/microglial
marker ED1 (Fig. 6F2), suggesting that activated micro-
glia are a source for MIP-1; in the developing cerebellum.
The somata and dendrites of Purkinje cells are also
immunopositive for MIP-1 (Fig. 6C–E and 6G, arrow-
heads). Little nonspecific staining is observed when non-
specific rabbit IgG is substituted for the MIP-1 antibody
(Fig. 6G2). Calbindin immunohistochemistry demon-
strates that the MIP-1-positive cells have the morphol-
ogy of Purkinje cells (Fig. 6G3).
Triple-immunofluorescent labeling
The above data suggest that CCR1 and MIP-1 are
expressed in both neurons and non-neuronal cells in the
developing cerebellum. To confirm the identity of the
CCR1- and MIP-1-expressing cells, we performed double-
and triple-immunofluorescence assays and analyzed the
specimens with confocal microscopy. In some cases, fluo-
rescence was collected from multiple planes (Z-series) to
reveal the morphology of cells and their processes (as
indicated below).
Figure 7 presents confocal images that demonstrate the
distribution of CCR1 immunoreactivity in each cerebellar
cell type. In the deep nucleus, CCR1 immunoreactivity is
most intense at P7 (see Fig. 2B3); Figure 7A shows that
CCR1 immunoreactivity colocalizes with NeuN, indicating
that CCR1 is expressed by deep nucleus neurons. In the
IGL, at the peak of CCR1 expression (P14; see Fig. 2C),
most CCR1-immunoreactive cells are neurons (NeuN-pos-
itive; Fig. 7B). A minority of CCR1-positive cells are as-
trocytes with GFAP-positive cell bodies and processes
(Fig. 7C; Z-series). Also in the IGL at P14, a few CCR1-
positive cell bodies display the isolectin-positive elaborate
processes of resting microglia (Fig. 7D; Z-series). Some
resting microglia express CCR1 (Fig. 7D, solid arrow-
heads), whereas others do not (Fig. 7D, open arrowheads).
Numerous CCR1-positive NeuN-negative cells are con-
centrated in cerebellar white matter at P7 (Fig. 7E). Most
of these cells have GFAP-positive processes (Fig. 7F, ar-
rowheads). Activated microglia (ED1-labeled) rarely ex-
press CCR1, and CCR1 immunoreactivity never colocal-
izes with CNPase (not shown). Of interest, in regions of
white matter where CCR1-positive astrocytes are found,
MIP-1-expressing activated microglia are observed (Fig.
7G). MIP-1 immunoreactivity is concentrated adjacent to
the nucleus [stained with propidium iodide (PI)], in a
pattern similar to the staining of Golgi apparatus (Lore et
al., 1998).
Fig. 3. Distribution of cerebellar CCR1 immunoreactivity from P7
to P21. Each row includes corresponding image montages of cresyl
violet staining (left column), CCR1 immunohistochemistry (middle
column), and the negative control (right column; assay performed
using CCR1 antibody, preincubated with a blocking peptide). Results
are compared on P7 (A1–A3), P14 (B1–B3), and P21 (C1–C3). The layers
of the cerebellar hemisphere are labeled accordingly. A: On P7, CCR1
immunoreactivity (A2) is concentrated on large cells in the PL (arrow-
heads) and on numerous cells with the morphology of granule cells
and Golgi cells (filled arrows) throughout the forming IGL. In the ML,
cells immunoreactive for CCR1 are occasionally identified (open ar-
rowhead). Little immunoreactivity is present in the EGL. B: On P14,
few large cells in the PL are immunoreactive for CCR1 (B2, filled
arrowheads); however, many smaller cell bodies express CCR1 within
and just superficial to the PL (arrows). CCR1-positive cells are more
widely distributed throughout the ML (open arrows) and include
occasional spindle-shaped descending granule cells (open arrowhead).
In the IGL, there are many immunoreactive granule cells. Little
specific staining is present in the EGL. C: On P21, no large CCR1-
positive cell bodies are found in the PL, whereas granule cells in the
IGL remain immunoreactive. In the ML, there are many CCR1-
immunoreactive cells, including those with darkly stained cell somata
in the upper ML (filled arrowheads), less intensely immunostained
cells with signal often limited to the cell surface in the lower ML
(arrows), and occasional descending granule cells (open arrowhead).
Nonspecific staining is limited to the pia in all negative controls. For
abbreviations, see list. Scale bars  25 m in A–C.
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Fig. 4. Changes in CCR1 immunostaining and neural and glial
markers in cerebellar cortex from P7 to P21. Each column includes
results of assays on serial cerebellar sections, obtained at P7 (left
column), P14 (middle column), and P21 (right column). A: Cresyl
violet (CV) staining reveals the thinning of the EGL, expansion of the
ML, and organization of the PL and IGL by P21. B: CCR1 immuno-
histochemistry demonstrates major changes in the distribution of
CCR1 expression between P7 and P21; in B2, arrowheads point to
small immunoreactive cells in the PL. C: The distribution of NeuN-
immunoreactive neurons also changes substantially over this period
and, in general, corresponds to the redistribution of cresyl violet-
stained cells. However, at P21, there are fewer NeuN-positive cells in
the ML (C3) than cresyl-violet-stained (A3) or CCR1-immunoreactive
cells (B3). D: Calbindin immunohistochemistry illustrates marked
developmental changes in Purkinje cells from P7 to P21; these cells
extend their dendrites to form a dense network in the ML by P21 (D3).
E: During the same time interval, there are prominent maturational
changes in Bergmann glia and a marked increase in GFAP immuno-
staining of glial processes in the ML; of note, at P14, in the PL,
GFAP-positive cell bodies (arrows in E2) are concentrated in the same
regions as CCR1-positive cells (arrows in B2). F: Isolectin B4 histo-
chemistry (to identify microglia and capillaries) indicates that there
are few microglia (arrowheads) in the cerebellar lobules between P7
and P21. For abbreviations, see list. Scale bar  50 m in A–F.
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Fig. 5. Changes in CCR1 immunostaining and cellular distribu-
tion in cerebellar white matter from P7-21. Each column includes
results of assays on serial cerebellar sections, obtained at P7 (left
column), P14 (middle column) and P21 (right column). Black lines
drawn in A1-A3 define the border between the WM and the IGL.
A: Cresyl violet (CV) staining reveals the high density of cell bodies in
the WM at P7 (A1) and P14 (A2) and the reduction in cell density at
P21 (A3). B: CCR1 immunohistochemistry identifies numerous CCR1-
positive cells in the WM at P7 (B1) and P14 (B2) and the absence of
staining in WM on P21 (B3). C: There is little NeuN immunoreactivity
in the WM at all time points. D: Many GFAP-positive astrocytes are
present in WM at all three ages; cell density appears highest at P14
(D2). E: In contrast, ED1-immunostained physiologically activated
microglia are concentrated in WM at P7 (E1) and P14 (E2) but are
absent by P21 (E3). F: Oligodendroglial cell bodies and processes,
detectable with CNPase immunohistochemistry, are evident on P14
(F2) and P21 (F3). For abbreviations, see list. Scale bar  50 m in
A–F.
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Figure 7H–J demonstrates the marked developmental
change in Purkinje cell CCR1 expression. In the PL at P7, all
calbindin-positive Purkinje cells express CCR1 (Fig. 7H). At
P14, fewer Purkinje cells express CCR1 (Fig. 7I), and at P21,
when their dendritic trees have reached their full extent (see
Fig. 4D3), no Purkinje cells are CCR1-positive (Fig. 7J).
Fig. 6. Macrophage inflammatory protein-1 immunoreactivity in
the postnatal rat cerebellum. In the cerebellar cortex, MIP-1 immu-
noreactivity is absent at P3 (A) and infrequently observed on cells in
the PL at P7 (arrow, B). Immunostaining is more intense at P14 (C),
with some Purkinje cells, but not all, immunoreactive for MIP-1. In
P21 (D) and adult (E) cerebellum, Purkinje cells are more uniformly
stained. MIP-1 immunoreactivity is detectable in the cell soma as
well as in apical dendrites (arrowheads, C–E). In the white matter on
P7, “juxtanuclear” MIP-1 (arrows in F1 see text) is identified, coin-
ciding with the distribution of physiologically activated microglia
(serial section, immunohistochemistry for monocytic marker ED1, F2).
In adult cerebellum, the cytoplasmic and dendritic distribution of
MIP-1 in Purkinje cells is evident (arrowheads, G1). The negative
control section, in which species-matched IgG was substituted for the
MIP-1 antibody, confirms the specificity of MIP-1 immunostaining
(G2), and calbindin immunohistochemistry confirms that MIP-1-
immunoreactive cells have the morphology of calbindin-
immunoreactive Purkinje cells (G3). For abbreviations, see list. Scale
bars 50 m in A–E; 25 m in F,G.
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Figure 7K and L focuses on the other CCR1-positive cell
types within and near the PL at P14. Smaller, intensely
immunoreactive cells in the PL are calbindin-negative
(not shown) but display the characteristic GFAP-positive
apical processes of Bergmann glia (Fig. 7K, arrows;
Z-series). Intense GFAP immunoreactivity is observed at
the base of the radial fibers, adjacent to the CCR1-positive
cell body (Fig. 7K, solid arrowheads). Juxtaposed with the
radial fibers are GFAP-negative CCR1-positive cell bodies
(Fig. 7K, open arrowheads). The CCR1-positive Bergmann
glia are found directly between or below Purkinje cells
(Fig. 7L) and have vertically oriented, oblong cell bodies
(Fig. 7L, arrows). CCR1-positive cells with a rounded mor-
phology are situated above the PL, at the PL/ML border,
and are unassociated with GFAP-positive fibers (Fig. 7L,
arrowhead). Most likely, these are the interneurons of the
lower ML (basket cells; see below).
Figure 7M illustrates that at P21, CCR1-expressing
cells are absent from the PL/ML border and are, instead,
distributed throughout the ML (Fig. 7M2). Purkinje cells
(Fig. 7M, arrowheads) are CCR1-negative but express
MIP-1 (Fig. 7M3 and M4, light blue color). The CCR1-
positive cells in the ML are closely associated with the
dendrites of the MIP-1-positive Purkinje cells (Fig. 7M2
and M4, arrows).
Doublecortin (DCx), a microtubule-associated protein, is
expressed in migrating neurons (Gleeson et al., 1999). The
rapidly changing distribution of CCR1 in the developing
cerebellum (described above) prompted us to hypothesize
that CCR1-expressing neurons also express DCx. How-
ever, we found no colocalization of DCx and CCR1. On
P14, DCx immunoreactivity is concentrated in the post-
mitotic, differentiating zone of the EGL (EGLd; Fig. 7N),
where little CCR1 is detected (Fig. 7N; see also Fig. 3A,B),
and throughout the cytoplasmic spindles of NeuN-positive
descending granule cells (Z-series; Fig. 7O).
At P21, numerous neurons with DCx-immunoreactive
spindles are seen traversing the ML, in between CCR1-
positive interneurons (Fig. 7P); these descending NeuN-
positive granule cells (Fig. 7P1, solid arrowheads) do not
express CCR1 (Fig. 7P2). CCR1-immunoreactive cells in
the P21 ML are not immunoreactive for DCx or NeuN
(Fig. 7P, open arrowheads). Based on the morphology of
the CCR1-immunoreactive cells and given that the only
cell bodies present in the P14/P21 ML are those of inter-
neurons and descending granule cells (Altman and Bayer,
1997), we can conclude that the NeuN-negative, CCR1-
positive cell bodies in the P14 and P21 ML are interneu-
rons.
Summary
Figure 8 graphically summarizes the developmental
changes in the intensity and cell specificity of CCR1 ex-
pression in the cerebellum. The intensity of the shading
corresponds with the overall intensity of CCR1 immuno-
reactivity in each cell population. CCR1 expression peaks
transiently in both neuronal and non-neuronal cells and is
completely absent from all cell types in the adult cerebel-
lum except the granule cell.
DISCUSSION
These results demonstrate that CCR1 expression is de-
velopmentally regulated in both neurons and glia in the
rat cerebellum. Our data also indicate that the CCR1
ligand MIP-1 is expressed in white matter microglia and
Purkinje cells. Most notably, in the developing cerebellum,
MIP-1-immunoreactive cells are located near the cell
bodies and processes of CCR1-expressing cells, specifically
at times of neuronal and astrocytic maturation (see be-
low). These findings suggest that CCR1 and MIP-1 may
play a role in cerebellar development in the rat.
CCR1 mRNA was detected in cerebellum at all ages
evaluated and was most abundant in adult brain, whereas
CCR1 immunoreactivity peaked earlier, between P7 and
P21. This finding suggests that CCR1 expression is post-
transcriptionally regulated during postnatal cerebellar
development.
CCR1 immunohistochemistry in relation to
neurite extension and cell maturation
Neuronal maturation is characterized by neurite exten-
sion, acquisition of adult cellular morphology, and synap-
togenesis. CCR1 immunoreactivity peaked transiently
during neurite extension and maturation in granule cells
(P10–P21), lower ML interneurons (basket cells; P15),
upper ML interneurons (stellate cells; P21–P30), Purkinje
cells (P7–P21), and Golgi cells (P14). CCR1 also peaked
during the maturation of Bergmann glia (P12–P15) and
astrocytes of the IGL (bushy astrocytes; P15) (Altman,
1972a–c; Altman and Bayer, 1997). Most of these cells
were forming synapses or contacts with Purkinje den-
drites or cell bodies during this phase. For example, the
peak of CCR1 expression in Bergmann glia coincided with
the so-called gliogenic phase (P12–P15), during which
Bergmann glial fibers ensheath areas of mature synapses
along Purkinje cell dendrites (Altman, 1972b). Interest-
ingly, at the times of peak CCR1 immunoreactivity in
most cell types, Purkinje cells were immunoreactive for
MIP-1.
In contrast, the peak immunoreactivity for CCR1 in
deep nucleus neurons (P7) did not directly coincide with
neurite extension and maturation [E22; (Altman and
Bayer, 1997)]. Instead, peak CCR1 expression coincided
with the maturation of afferent Purkinje axons [the for-
mation of dense axonal fibrils, (Altman and Bayer, 1997)]
and the initiation of MIP-1 expression in Purkinje cell
bodies.
Intracellular CCR1 immunoreactivity
In all CCR1-immunoreactive cell types, immunoreactiv-
ity was concentrated in the cytoplasm and the nucleus but
was absent on cell processes. The cytoplasmic localization
of chemokine receptors in neurons has been reported pre-
viously for CCR1, CCR3, CCR5, CXCR2, and CXCR4 (Hes-
selgesser et al., 1997; Bajetto et al., 1999; Klein et al.,
1999; Boutet et al., 2001), and other authors have de-
scribed “homogeneous cell staining” of chemokine recep-
tors, closely resembling the combined cytoplasmic and
nuclear CCR1 immunoreactivity we observed (Bajetto et
al., 1999; Klein et al., 1999). Cytoplasmic localization may
reflect ligand binding and internalization (Hesselgesser et
al., 1998; Zhao et al., 1998) or concentration of newly
synthesized protein within endoplasmic reticulum or
Golgi compartments; nuclear localization suggests that
this receptor may also have a role in intracellular signal
transduction or protein trafficking.
Several studies have documented the concentration of
chemokine receptors in neuronal processes (Klein et al.,
1999; Boutet et al., 2001; Westmoreland et al., 2002). We
did not detect CCR1 immunoreactivity on neuronal or
astrocytic processes; however, we did observe punctate
17CCR1 EXPRESSION IN DEVELOPING CEREBELLUM
Figure 7 (Continued)
18 R.M. COWELL AND F.S. SILVERSTEIN
Figure 7 (Continued)
19CCR1 EXPRESSION IN DEVELOPING CEREBELLUM
CCR1 immunostaining throughout the molecular layer,
which could be attributable to receptors on parallel fibers
or the neurites of basket, stellate, or Purkinje cells. De-
finitive localization of CCR1 to cell processes may require
more sensitive methods such as immunoelectron micros-
copy.
MIP-1 immunoreactivity
MIP-1 immunoreactivity was detected in microglia in
P7 and P14 cerebellar white matter and in Purkinje cells
from P7 into adulthood. Physiologically activated (amoe-
boid) microglia are concentrated in normal developing
white matter tracts and are involved in tissue remodeling
and phagocytosis of dying cells. In P7 rat forebrain, acti-
vated microglia in white matter express MIP-1, but these
cells disappear by P12 (Cowell et al., 2002). In cerebellar
white matter, however, MIP-1-positive amoeboid micro-
glia were identified at P7 and P14 (absent by P21). MIP-1
expression was never localized to resting, white matter
microglia; MIP-1 expression may depend on the micro-
glial activation state and/or the maturational phase of the
surrounding white matter.
Purkinje cell MIP-1 expression is a novel and unex-
pected finding. Reports of chemokine expression by neu-
rons are scarce (Coughlan et al., 2000); however, Meng et
al. (1999) documented the developmental expression of the
closely related -chemokine MCP-1 in Purkinje cells in
late gestational human brain and hypothesized that
MCP-1 is involved in Purkinje cell maturation. MIP-1-
immunoreactive Purkinje cells were observed in the vicin-
ity of the cell bodies or processes of CCR1-expressing cells
during development as well as in the adult, suggesting
that CCR1 and MIP-1 may have roles in normal cerebel-
lar physiology.
Although MIP-1 can stimulate increases in intracellu-
lar calcium via CCR1 in neurons in vitro (Meucci et al.,
1998), it is not known whether neuronal MIP-1 signaling
via CCR1 occurs in vivo. CCR1 and MIP-1 were ex-
pressed in the same neuroanatomical regions, whereas no
immunoreactivity for another CCR1 ligand RANTES or
the other main MIP-1 receptor CCR5 was detectable in
the cerebellum at any age. These observations suggest
that MIP-1 may be a functionally relevant ligand for
CCR1 in the developing cerebellum.
Function of CCR1 and MIP-1 in the
developing cerebellum
There is strong evidence implicating the chemokine re-
ceptor CXCR4 in the regulation of neuronal migration in
the mouse cerebellum; CXCR4 knockout (/) mice ex-
hibit increased EGL thickness and abnormal granule cell
positioning in early cerebellar development (Zou et al.,
1998). In contrast, CCR1 immunostaining was absent
from cells within the proliferating or premigratory zones
of the EGL, migrating descending granule cells were
rarely positive for CCR1, and few CCR1-immunoreactive
cells expressed doublecortin, a protein specifically ex-
pressed in migrating neurons (Gleeson et al., 1999). Fur-
thermore, preliminary evaluation of the cerebellar struc-
ture of adult CCR1 (/) mice with cresyl violet staining
and light microscopy revealed no abnormalities (unpub-
lished observations, RMC; mice generously provided by
Dr. Craig Gerard, Harvard University). However, this ob-
servation does not exclude a role for CCR1 in cerebellar
development; there may be some degree of functional re-
dundancy in this system that compensates for the lack of
CCR1, resulting in a normal phenotype.
We speculate that CCR1 could influence maturation-
related processes such as neurite extension and cell adhe-
sion. CCR1 is a G-protein-coupled receptor that, upon
activation, initiates a complex cascade of intracellular
events. In lymphocytes, MIP-1 binding to CCR1 activates
the phosphatidyl inositol-3 kinase (PI3-K) and proline-
rich tyrosine kinase/related focal adhesion tyrosine kinase
Fig. 7 (Overleaf). Cellular localization of CCR1 and MIP-1 in
cerebellum with confocal microscopy. Yellow color indicates colocal-
ization of green and red labels. Light blue indicates colocalization of
green and blue labels. Bright purple indicates colocalization of red
and blue labels. Each panel set represents the fluorescent signal
collected in a single confocal plane, unless otherwise specified. The
final panel in each set is the composite of the preceding panels (i.e., A3
is the composite of A1 and A2). A: In the deep nucleus at P7, all
NeuN-immunoreactive cell bodies are positive for CCR1. B: In the
IGL at P14, many CCR1-positive cell bodies are immunopositive for
the neuron-specific marker NeuN (arrowheads). C: In this same area,
GFAP-positive astrocytes (C1) have CCR1-positive cell bodies (C2;
arrowheads indicate the cell soma); colocalization was confirmed by
the collection of fluorescence every 0.5 m through a thickness of 6.0
m (Z-series), enabling the visualization GFAP-immunostained pro-
cesses. D: In P14 IGL, some isolectin-reactive resting microglia with
elaborate processes displayed immunoreactivity for CCR1 (solid ar-
rowhead), whereas some did not (open arrowhead); 6.0 m Z-series.
E: At P7, NeuN-labeled neurons of the IGL border the white matter
(WM) in E1; numerous CCR1-positive cells are present in areas devoid
of neurons (arrowheads, E2, E3). F: In P7 WM, CCR1 immunoreactiv-
ity does not colocalize with the microglial marker ED1 but is found on
astrocyte cell bodies (arrowheads). G: In P7 WM, physiologically ac-
tivated (ED1-positive) microglia (G1) exhibit MIP-1 immunoreactiv-
ity (G2) concentrated adjacent to the cell nucleus, stained with the
nucleic acid marker propidium iodide (PI; G3). H: In the PL on P7,
CCR1 immunoreactivity colocalizes with the Purkinje cell marker
calbindin (arrowheads). I: On P14, intense CCR1 immunoreactivity is
occasionally present in Purkinje cell bodies (arrowhead). J: On P21,
calbindin-positive Purkinje cells are no longer CCR1-immunoreactive
but are bordered by smaller CCR1-positive cell bodies. K: In the PL on
P14, CCR1-positive cell bodies (solid arrowheads, K2, K3) have GFAP-
stained apical processes (arrows, K1, K3), confirming their identity as
Bergmann glia. Other CCR1-immunoreactive cell bodies are scattered
in the ML (open arrowheads, K2, K3) in a distribution similar to that
of ML interneurons. Fluorescence was collected every 0.5 m through
a thickness of 5.0 m for these images. L: Cells of different morphol-
ogies (vertically aligned and oblong, arrows; round, arrowheads) are
present in the PL, closely apposed to calbindin-positive Purkinje cells.
The oblong cells are associated with GFAP-positive apical processes,
whereas the round cells are not. M: In P21 cerebellum, calbindin-
labeled Purkinje cells (arrowheads, M1) no longer express CCR1 (M2)
but are immunoreactive for MIP-1 (M3). CCR1-positive cells in the
ML are closely associated with MIP-1-positive Purkinje dendrites
(arrows, M2, M4). N: Cells in the EGL are NeuN-positive (N1) but
CCR1-negative (N2). Doublecortin (DCx) is concentrated in the differ-
entiating zone of the EGL (EGLd, N3), in NeuN-positive cells (N4,
light blue color). O: NeuN-immunoreactive cells in the ML (O1) have
the morphology of descending granule cells and display DCx-positive
spindles (O2, O3). Fluorescence was captured from a 5.0-m Z-series.
P: On P21, NeuN-positive descending granule cells with DCx-
immunoreactive spindles are evident in the ML (solid arrowheads)
interspersed with CCR1-positive cell bodies that are NeuN- and DCx-
negative (open arrowheads). For abbreviations, see list. Scale bars 
20 m in A–C; 12.5 m in D,F,G,K; 50 m in E; 25 m in H–J,L–N,P;
10 m in O.
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(Pyk2/RAFTK) pathway, resulting in migration (Rumsey
et al., 2001). However, in cerebellar neurons, activation of
this pathway by growth factors induces differentiation,
neurite and growth cone formation (Menegon et al., 1999;
Ivankovic-Dikic et al., 2000; Park et al., 2000), and sur-
vival (Dudek et al., 1997). Of interest, the developmental
and cell-specific expression of the PI3-K regulatory sub-
units p55 and p55	 is similar to that of CCR1 (Trejo and
Pons, 2001). p55, in particular, is expressed by Purkinje
cells early in development (P1) and basket cells later
(P20).
Recently, Weber et al. (2001) demonstrated that CCR1
mediates leukocyte adhesion to capillary endothelium.
Chemokine-mediated cell adhesion and membrane polar-
ization (specialization) can also occur via the PI3-K path-
way (Manes et al., 2000; Rodriguez-Frade et al., 2001),
raising the possibility that chemokines may stimulate ad-
hesion and membrane polarization in cerebellar neurons.
In fact, there are marked similarities between the cere-
bellar distribution of CCR1 expression and the distribu-
tions of the synaptogenesis-related cell adhesion mole-
cules Tyro-3 (Prieto et al., 2000), 2L4 (Wallis et al., 1992),
and 5B4-cellular adhesion molecule (5B4-CAM) (Alcant-
ara et al., 1992).
MIP-1 binding to CCR1 can stimulate gene transcrip-
tion and influence neuronal signaling as well (Miller and
Oh, 2002). MIP-1 induces transcriptional activation of
the proto-oncogene c-fos in T cells by stimulating the
translocation of signal transducer (STAT) to the nucleus
(Wong and Fish, 1998), and MIP-1-induced changes in
intracellular calcium concentrations could strengthen
nascent synapses and influence neurotransmitter release
and neuronal survival in development (Giovannelli et al.,
1998; Mattson and Furukawa, 1998; Meucci et al., 1998;
Kaul and Lipton, 1999; Klein et al., 1999).
CCR1 activation may have different functions in cere-
bellar glia, such as promoting migration, proliferation,
and survival. At P7 and P14, CCR1-expressing astrocytes
were located amidst MIP-1-immunoreactive microglia in
the cerebellar white matter. CCR1 activation may be par-
ticularly important in white matter at P7, when there is
pronounced astrocyte proliferation (Zhang and Goldman,
1996) and programmed cell death (Krueger et al., 1995).
In vitro, the CCR1 ligand RANTES promotes the survival
of human fetal astrocytes (Bakhiet et al., 2001), and acti-
vation of the PI3-K/pyk2 pathway in astrocytes promotes
DNA synthesis and proliferation (Cazaubon et al., 1997;
Bajetto et al., 1999; Schinkmann et al., 2000). In addition,
MIP-1 can stimulate the migration of CCR1-bearing as-
trocytes in vitro (Tanabe et al., 1997); this may be relevant
for astrocytes that migrate from their site of origin in the
cerebellar white matter to the IGL (Zhang and Goldman,
1996).
There is growing recognition that intrauterine or peri-
natal infection can disrupt brain development. Analysis of
CCR1 function and distribution in the developing cerebel-
lum may elucidate a link between infection and cerebellar
malformation. For example, infection of P1 rats with the
Borna virus [as a model of autism (Pletnikov et al., 1999);
for review, see Carbone et al., 2001] induces the upregu-
lation of the CCR1 ligand RANTES in the cerebellum; the
magnitude of chemokine expression correlates with the
degree of motor learning impairment (Sauder et al., 2001).
Also, injection of a polytropic murine retrovirus stimu-
lates the production of RANTES and MIP-1 in the neo-
natal mouse cerebellum, accompanied by the rapid onset
Fig. 8. Trends in CCR1 immunoreactivity in P3-adult cerebellum.
CCR1-immunoreactive neurons (A) and glia (B) were identified by
their location and morphology and/or by the colocalization of CCR1
with specific cell markers (confocal microscopy; see Materials and
Methods). The shading intensity represents the intensity of CCR1
immunoreactivity in the specified cell population. , peak; ,
intense; , light; , none.
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of ataxia and seizures (Peterson et al., 2001). Overactiva-
tion of CCR1 may be responsible for the neuronal cell
death and/or alterations in neurotransmission in these
models (Hornig et al., 1999; Carbone et al., 2001).
The findings presented in this study support the hy-
pothesis that chemokines and their receptors are involved
in cerebellar development. Future studies will focus on
determining the roles of specific chemokine/chemokine re-
ceptor pairs in development and neuropathology.
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